CARving the Path to Allogeneic CAR T Cell Therapy in Acute Myeloid Leukemia

Despite advances in the understanding of the genetic landscape of acute myeloid leukemia (AML) and the addition of targeted biological and epigenetic therapies to the available armamentarium, achieving long-term disease-free survival remains an unmet need. Building on growing knowledge of the intera...

Descripción completa

Detalles Bibliográficos
Autores principales: Pasvolsky, Oren, Daher, May, Alatrash, Gheath, Marin, David, Daver, Naval, Ravandi, Farhad, Rezvani, Katy, Shpall, Elizabeth, Kebriaei, Partow
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8784883/
https://www.ncbi.nlm.nih.gov/pubmed/35083154
http://dx.doi.org/10.3389/fonc.2021.800110

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8784883/
https://www.ncbi.nlm.nih.gov/pubmed/35083154
http://dx.doi.org/10.3389/fonc.2021.800110

Ejemplares similares